These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 13365999)
21. Effect of heparin on circulating Walker carcinosarcoma 256 cells. AGOSTINO D; GROSSI CE; CLIFFTON EE J Natl Cancer Inst; 1961 Jul; 27():17-24. PubMed ID: 13681661 [No Abstract] [Full Text] [Related]
22. The effect of hyperlipemia on pulmonary metastases of Walker 256 carcinosarcoma in the rat. CLIFFTON EE; AGOSTINO D; MINDE K Cancer Res; 1961 Sep; 21():1062-7. PubMed ID: 13694102 [No Abstract] [Full Text] [Related]
23. The effect of cancer inhibitor drugs on the take of Walker carcinosarcoma 256 in rats. MCDONALD GO; CRUZ EP; COLE WH Surg Forum; 1957; 7():486-9. PubMed ID: 13433422 [No Abstract] [Full Text] [Related]
24. Walker carcinosarcoma 256 tissue as a dietary constituent. I. Stimulation of appetite and growth in the tumor-bearing rat. MILLAR FK; WHITE J; BROOKS RH; MIDER GB J Natl Cancer Inst; 1957 Nov; 19(5):957-87. PubMed ID: 13502752 [No Abstract] [Full Text] [Related]
25. Incorporation of canavanine into protein of Walker carcinosarcoma 256 cells cultured in vitro. KRUSE PF; WHITE PB; CARTER HA; McCOY TA Cancer Res; 1959 Jan; 19(1):122-5. PubMed ID: 13618897 [No Abstract] [Full Text] [Related]
26. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat. Kooistra KL; Rodriguez M; Powis G Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564 [TBL] [Abstract][Full Text] [Related]
27. [Growth and transplantability of Walker carcinoma 256 in the peritoneal cavity of C. River rats]. VERGA V; AGOSTINO D Riv Anat Patol Oncol; 1956 Sep; 11(7):877-85. PubMed ID: 13442496 [No Abstract] [Full Text] [Related]
28. Walker carcinosarcoma 256 tissue as a dietary constituent. II. Effect upon growth and nitrogen excretion in the normal rat. WHITE J; TOAL JN; MILLAR FK; COOL HT; MIDER GB J Natl Cancer Inst; 1957 Nov; 19(5):969-75. PubMed ID: 13502753 [No Abstract] [Full Text] [Related]
29. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551 [TBL] [Abstract][Full Text] [Related]
30. The effect of human fibrinolysin on survival of carcinosarcoma 256 Walker cells in the blood. GROSSI CE; AGOSTINO D; MELAMED M; CLIFFTON EE Cancer; 1961; 14():957-62. PubMed ID: 13709068 [No Abstract] [Full Text] [Related]
31. Studies on the uptake of vitamin B12-Co60 by the hamster methylcholanthrene-induced sarcoma and the rat Walker carcinosarcoma. GAULL G; LEMON HM; MILLER A; ROSS JF Cancer Res; 1956 Oct; 16(9):842-7. PubMed ID: 13364913 [No Abstract] [Full Text] [Related]
32. [Experimental animal studies on the regional perfusion of tumors of the extremities]. Brock N; Niekamp T Arzneimittelforschung; 1968 Jan; 18(1):1-7. PubMed ID: 5754938 [No Abstract] [Full Text] [Related]
33. Serum lipoproteins in rats with tumors induced by 9,10-dimethyl-1,2-benzanthracene and with transplanted Walker carcinosarcoma 256. Barclay M; Skipski VP; Terebus-Kekish O; Merker PL; Cappuccino JG Cancer Res; 1967 Jun; 27(6):1158-67. PubMed ID: 6066623 [No Abstract] [Full Text] [Related]
34. [Experimental analysis of operative effects on nerve regeneration homo- and heterospecific tissues studied with transplants obtained by means of a new technic of intraparenchymal-corneal transplant. II. Neuroregenerative accelerating effects of fragments of the Walker 256 carcinosarcoma transplanted in parenchymal tissue in the cornea]. Craviotto C; Carlevaro G Riv Anat Patol Oncol; 1965; 27(3):425-41. PubMed ID: 5886069 [No Abstract] [Full Text] [Related]
35. [Basic and salvage pathways of NAD biosynthesis in organs of normal rats, tumor-bearing rats and in tumors]. Reztsova VV; Filov VA; Ivin BA; Kon'kov SA; Krylova IM Vopr Onkol; 1994; 40(1-3):68-71. PubMed ID: 7701797 [TBL] [Abstract][Full Text] [Related]
36. Contact guidance of Walker carcinosarcoma cells by the underlying normal fibroblasts is inhibited by RGD-containing synthetic peptides. Madeja Z; Sroka J Folia Histochem Cytobiol; 2002; 40(3):251-60. PubMed ID: 12219835 [TBL] [Abstract][Full Text] [Related]
37. [Quantitative studies in rats on the resistance of various organs to inoculated tumor cells]. Schmähl D; Osswald H; Prochotta L Z Krebsforsch; 1967; 70(2):130-7. PubMed ID: 4174095 [No Abstract] [Full Text] [Related]
38. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells. Boroday NV; Chekhun VF Exp Oncol; 2018 Mar; 40(1):42-47. PubMed ID: 29600974 [TBL] [Abstract][Full Text] [Related]
39. [Blood circulation and oxygen consumption of tissue-isolated implanted tumors (DS-carcinosarcoma) in vivo]. Schwarz W; Schulz V; Kersten M; Wörz R; Vaupel P Z Krebsforsch; 1971 Feb; 75(3):161-73. PubMed ID: 4256413 [No Abstract] [Full Text] [Related]
40. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone. Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]